Search for:

Tuesday 29th April 2008

Print
Email
Text size
Comment

New VC fund to focus on life sciences

Fountain Healthcare Partners, a Dublin-headquartered venture capitalist (VC), has closed its inaugural fund at €75 million (£59 million). Most of the money will be invested in the life science sector in Europe, with a primary focus on Ireland.

The fund, which has a second office in New York, is targeting a final close at €100 million.

More than 90 per cent of the capital raised so far is from institutional investors, of which most are based in Ireland. They include government-backed Enterprise Ireland, the National Pension Reserve Fund (of Ireland) and the European Investment Fund.

The fund will invest in companies that have product development programmes with a well-defined route to commercialisation and exit. Its management intends to invest a total of between €500,000 and €7 million per company across several rounds, in conjunction with other life science-focused VC firms.

The Irish government will have invested more than €8 billion between 2000 and 2008 to accelerate development of indigenous science and technology ventures. It intends to invest a further €8.2 billion between 2006 and 2013.

Comments [0]

User Comments

There are currently no comments on this post.

 

Related Articles


People who read this article also read ...

Related sections

Interesting links

 
Would you float on AIM?
No chance
Maybe in the future
We're already listed

Editor's Pick

Bad debt, the bane of the growing business, is on the rise. David Gordon, a solicitor at London-based commercial law firm DG Law, explains how to deal with this most soul-destroying of problems.
 

Other Finance

Deal Round-up (05.09.2008)
Deal Round-up (04.09.2008)
Deal Round-up (03.09.2008)

Advice

How to float on AIM
Corporate hospitality
Managing your wealth

Growth Issues

Delisting: the great escape
Doing business in Russia
UK businesses in India

Research

Cash shells’ resources multiply
Powering a renewable revolution
How to improve your year-end numbers

Profile

Entrepreneurial to the core
The art of smart buying
Murphy’s law

Case Studies

David Reiss: staying in control
A tale of two spin-outs
Taking a fresh approach
  Job Vacancies | About Us | Contact | Disclaimer | Copyright | Privacy Policy |Site Map